Literature DB >> 27547779

Method for Efficient Transduction of Cancer Stem Cells.

Kiera Walker1, Anita Hjelmeland1.   

Abstract

Ectopic gene expression through introduction of cDNA and gene silencing by RNA interference each facilitate the elucidation of molecular pathways in both normal and pathologic states. As transfection efficiency in some primary and established cells is low, lentivirus based expression systems with high infection rates can improve experimental design. For example, glioblastoma cells and particularly the cancer stem cell (CSC) fraction can be difficult to transfect but are amenable to viral infection. Greater utilization of lentivirus for expression of cDNA and shRNA in CSCs may be limited due to technical challenges, including elimination of pro-differentiating fetal bovine serum (FBS). We therefore generated a subline of 293Ts that can proliferate and efficiently produce virus in CSC media, designated CSC293Ts. We provide detailed protocols for the generation of CSC293Ts and for the production of lentivirus for CSC infection using glioblastoma as a model. Our data demonstrate that serum free media from CSC293Ts consistently produces greater than 80% infection rates without virus concentration. We believe that the detailed protocols provided here can be adapted for multiple cell types for broad utility.

Entities:  

Keywords:  cancer stem cell infection; cellular transduction; lentivirus

Year:  2014        PMID: 27547779      PMCID: PMC4989917          DOI: 10.14343/JCSCR.2014.2e1008

Source DB:  PubMed          Journal:  J Cancer Stem Cell Res        ISSN: 2329-5872


  8 in total

1.  Titering lentiviral vectors: comparison of DNA, RNA and marker expression methods.

Authors:  L Sastry; T Johnson; M J Hobson; B Smucker; K Cornetta
Journal:  Gene Ther       Date:  2002-09       Impact factor: 5.250

Review 2.  Lentiviral vectors: optimization of packaging, transduction and gene expression.

Authors:  Christophe Delenda
Journal:  J Gene Med       Date:  2004-02       Impact factor: 4.565

3.  Packaging HIV- or FIV-based lentivector expression constructs and transduction of VSV-G pseudotyped viral particles.

Authors:  Amy Mendenhall; Jacob Lesnik; Chandreyee Mukherjee; Travis Antes; Ranjita Sengupta
Journal:  J Vis Exp       Date:  2012-04-08       Impact factor: 1.355

Review 4.  Cancer stem cells, cancer cell plasticity and radiation therapy.

Authors:  Erina Vlashi; Frank Pajonk
Journal:  Semin Cancer Biol       Date:  2014-07-12       Impact factor: 15.707

Review 5.  Tackling the cancer stem cells - what challenges do they pose?

Authors:  Diwakar R Pattabiraman; Robert A Weinberg
Journal:  Nat Rev Drug Discov       Date:  2014-07       Impact factor: 84.694

Review 6.  Stem cells, cancer, and cancer stem cells.

Authors:  T Reya; S J Morrison; M F Clarke; I L Weissman
Journal:  Nature       Date:  2001-11-01       Impact factor: 49.962

Review 7.  Cancer stem cells in gliomas: identifying and understanding the apex cell in cancer's hierarchy.

Authors:  Monica Venere; Howard A Fine; Peter B Dirks; Jeremy N Rich
Journal:  Glia       Date:  2011-05-05       Impact factor: 7.452

Review 8.  Cancer stem cells: impact, heterogeneity, and uncertainty.

Authors:  Jeffrey A Magee; Elena Piskounova; Sean J Morrison
Journal:  Cancer Cell       Date:  2012-03-20       Impact factor: 31.743

  8 in total
  8 in total

1.  N-cadherin upregulation mediates adaptive radioresistance in glioblastoma.

Authors:  Satoru Osuka; Dan Zhu; Zhaobin Zhang; Chaoxi Li; Christian T Stackhouse; Oltea Sampetrean; Jeffrey J Olson; G Yancey Gillespie; Hideyuki Saya; Christopher D Willey; Erwin G Van Meir
Journal:  J Clin Invest       Date:  2021-03-15       Impact factor: 14.808

2.  Reactive species balance via GTP cyclohydrolase I regulates glioblastoma growth and tumor initiating cell maintenance.

Authors:  Anh Nhat Tran; Kiera Walker; David G Harrison; Wei Chen; James Mobley; Lauren Hocevar; James R Hackney; Randee S Sedaka; Jennifer S Pollock; Matthew S Goldberg; Dolores Hambardzumyan; Sara J Cooper; Yancey Gillespie; Anita B Hjelmeland
Journal:  Neuro Oncol       Date:  2018-07-05       Impact factor: 12.300

3.  UAB30, a novel RXR agonist, decreases tumorigenesis and leptomeningeal disease in group 3 medulloblastoma patient-derived xenografts.

Authors:  Evan F Garner; Laura L Stafman; Adele P Williams; Jamie M Aye; Caroline Goolsby; Venkatram R Atigadda; Blake P Moore; Li Nan; Jerry E Stewart; Anita B Hjelmeland; Gregory K Friedman; Elizabeth A Beierle
Journal:  J Neurooncol       Date:  2018-08-21       Impact factor: 4.130

4.  Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.

Authors:  Jiping Wang; Jianmei W Leavenworth; Anita B Hjelmeland; Reed Smith; Neha Patel; Ben Borg; Ying Si; Peter H King
Journal:  Glia       Date:  2019-08-10       Impact factor: 7.452

5.  Targeting Acid Ceramidase Inhibits Glioblastoma Cell Migration through Decreased AKT Signaling.

Authors:  Cyntanna C Hawkins; Amber B Jones; Emily R Gordon; Sarah E Williford; Yuvika Harsh; Julia K Ziebro; Catherine J Landis; Sajina Gc; David K Crossman; Sara J Cooper; Sasanka Ramanadham; Ninh Doan; Anita B Hjelmeland
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

6.  A role for GLUT3 in glioblastoma cell invasion that is not recapitulated by GLUT1.

Authors:  Catherine J Libby; Sajina Gc; Gloria A Benavides; Jennifer L Fisher; Sarah E Williford; Sixue Zhang; Anh Nhat Tran; Emily R Gordon; Amber B Jones; Kaysaw Tuy; William Flavahan; Juan Gordillo; Ashlee Long; Sara J Cooper; Brittany N Lasseigne; Corinne E Augelli-Szafran; Victor Darley-Usmar; Anita B Hjelmeland
Journal:  Cell Adh Migr       Date:  2021-12       Impact factor: 3.405

7.  Intracranially injectable multi-siRNA nanomedicine for the inhibition of glioma stem cells.

Authors:  Cheripelil Abraham Manju; Kottarapat Jeena; Ranjith Ramachandran; Maneesh Manohar; Anna Mathew Ambily; Koythatta Meethalveedu Sajesh; Genekehal Siddaramana Gowd; Krishnakumar Menon; Keechilat Pavithran; Ashok Pillai; Shantikumar V Nair; Manzoor Koyakutty
Journal:  Neurooncol Adv       Date:  2021-08-18

Review 8.  Patient-Derived Cancer Organoids for Precision Oncology Treatment.

Authors:  Mark N Pernik; Cylaina E Bird; Jeffrey I Traylor; Diana D Shi; Timothy E Richardson; Samuel K McBrayer; Kalil G Abdullah
Journal:  J Pers Med       Date:  2021-05-17
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.